Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

N-acyl amines [FA0802]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA08020017 (+)N-(1S-methyl-propyl) arachidonoyl amine N-(1S-methyl-propyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine NA 24:4 C24H41NO 359.318814
LMFA08020039 (+)N-(1S-methyl-2-hydroxy-ethyl) alpha,alpha-dimethylarachidonoyl amine N-(1S-methyl-2-hydroxy-ethyl)-2,2-dimethyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine NA 25:4;O C25H43NO2 389.329379
LMFA08020047 (-)N-(2R-hydroxy-propyl) alpha,alpha-dimethylarachidonoyl amine N-(2R-hydroxy-propyl)-2,2-dimethyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine NA 25:4;O C25H43NO2 389.329379
LMFA08020072 N-arachidonoyl dihydroxypropylamine N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-(1,3-dihydroxy-propyl-2-amine) NA 23:4;O2 C23H39NO3 377.292994
LMFA08020074 N-arachidonoyl GABA N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-gamma-aminobutyric acid NA 24:5;O2 C24H39NO3 389.292994
LMFA08020075 N-arachidonoyl taurine N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-taurine NAT 20:4 C22H37NO4S 411.244331
LMFA08020077 N-stearoyl glycine N-octadecanoyl-glycine NA 20:1;O2 C20H39NO3 341.292994
LMFA08020078 N-stearoyl taurine N-octadecanoyl-taurine NAT 18:0 C20H41NO4S 391.275631
LMFA08020080 N-palmitoyl taurine N-hexadecanoyl-taurine NAT 16:0 C18H37NO4S 363.244331
LMFA08020081 N-oleoyl taurine N-(9Z-octadecenoyl)-taurine C20H39NO4S 389.259981
LMFA08020083 N-docosanoyl taurine N-docosanoyl-taurine NAT 22:0 C24H49NO4S 447.338231
LMFA08020084 N-arachidonoyl dopamine N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-dopamine NA 28:8;O2 C28H41NO3 439.308644
LMFA08020085 Capsaicin 8-Methyl-N-vanillyl-6E-nonenamide NA 18:5;O2 C18H27NO3 305.199094
LMFA08020103 N-palmitoyl GABA N-hexadecanoyl-gamma-aminobutyric acid NA 20:1;O2 C20H39NO3 341.292994
LMFA08020104 N-oleoyl GABA N-(9Z-octadecenoyl)-gamma-aminobutyric acid NA 22:2;O2 C22H41NO3 367.308644
LMFA08020105 N-docosahexaenoyl GABA N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-gamma-aminobutyric acid NA 26:7;O2 C26H39NO3 413.292994
LMFA08020106 N-stearoyl GABA N-octadecanoyl-gamma-aminobutyric acid NA 22:1;O2 C22H43NO3 369.324294
LMFA08020138 N-linoleoyl taurine N-(9Z,12Z-octadecadienoyl)-taurine NAT 18:2 C20H37NO4S 387.244331
LMFA08020139 N-arachidonoyl-dopamine-d8 N-[2-(3,4-dihydroxyphenyl)ethyl]-5Z,8Z,11Z,14Z-eicosatetraenamide-5,6,8,9,11,12,14,15-d8 C28H33D8NO3 447.358860
LMFA08020140 N-Oleoyl Dopamine N-[2-(3,4-dihydroxyphenyl)ethyl]-9Z-octadecenamide NA 26:5;O2 C26H43NO3 417.324294
LMFA08020141 Arachidonoyl Serotonin N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-5Z,8Z,11Z,14Z-eicosatetraenamide C30H42N2O2 462.324628
LMFA08020142 N-methyl hexanamide N-methyl hexanoyl amine NA 7:0 C7H15NO 129.115364
LMFA08020147 12-HETE-GABA N-(12S-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoyl)-gamma-aminobutyric acid NA 24:5;O3 C24H39NO4 405.287909
LMFA08020148 15-HETE-GABA N-(15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-gamma-aminobutyric acid NA 24:5;O3 C24H39NO4 405.287909
LMFA08020149 15-HETE-T N-(15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-taurine NAT 20:4;O C22H37NO5S 427.239246
LMFA08020150 12-HETE-T N-(12S-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoyl)-taurine NAT 20:4;O C22H37NO5S 427.239246
LMFA08020151 15-HETE-DA N-(15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-dopamine NA 28:8;O3 C28H41NO4 455.303559
LMFA08020152 15-HETE-VA N-(15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-vanillylamine NA 28:8;O3 C28H41NO4 455.303559
LMFA08020154 N-arachidonoyl vanillylamine N-(5Z,8Z,11Z,15Z-eicosatetraenoyl)-vanillylamine NA 28:8;O2 C28H41NO3 439.308644
LMFA08020155 Macamide N-hexadecanoyl benzylamine NA 23:4 C23H39NO 345.303164
LMFA08020156 Macamide N-octadecanoyl benzylamine NA 25:4 C25H43NO 373.334464
LMFA08020157 Macamide N-(9Z-octadecenoyl) benzylamine NA 25:5 C25H41NO 371.318814
LMFA08020158 Macamide N-(9Z,12Z-octadecadienoyl) benzylamine NA 25:6 C25H39NO 369.303164
LMFA08020159 Macamide N-(9Z,12Z,15Z-octadecatrienoyl) benzylamine NA 25:7 C25H37NO 367.287514
LMFA08020160 Macamide N-(5-oxo-6E,8E-octadecadienoyl) benzylamine NA 25:7;O C25H37NO2 383.282429
LMFA08020161 N-(2E,4E,10E,12Z-tetradecatetraen-8-yn-oyl) isobutylamine N-(2E,4E,10E,12Z-tetradecatetraen-8-yn-oyl) isobutylamine NA 18:6 C18H25NO 271.193614
LMFA08020162 (E,E)-2,4-Decadienoic isobutylamide (2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide NA 14:2 C14H25NO 223.193614
LMFA08020163 1-(4-carboxybutanamido)-1'-(dimethylcarbamoyl)ferrocene {(1,2,3,4,5-eta)-1-(4-carboxybutanamido)cyclopentadienyl}[(1,2,3,4,5-eta)-1-(dimethylcarbamoyl)cyclopentadienyl]iron C18H22N2O4Fe 386.092897
LMFA08020164 2,4-Undecadiene-8,10-diynoic acid isobutylamide (2E,4Z)-N-(2-methylpropyl)undeca-2,4-dien-8,10-diynamide NA 15:6 C15H19NO 229.146664
LMFA08020165 Anacyclin (2E,4E)-N-isobutyltetradeca-2,4-dien-8,10-diynamide NA 18:6 C18H25NO 271.193614
LMFA08020166 asukamycin (2E,4E,6E)-7-cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]hepta-2,4,6-trienamide C31H34N2O7 546.236603
LMFA08020167 beta-sanshool (2E,6E,8E,10E)-N-(2-methylpropyl)dodeca-2,6,8,10-tetraenamide NA 16:4 C16H25NO 247.193614
LMFA08020168 BRN 2646116 (2E,4E)-N-isobutyl-6-phenyl-hexa-2,4-dienamide NA 16:6 C16H21NO 243.162314
LMFA08020169 Deferoxamine N-(5-aminopentyl)-N-hydroxy-N'-[5-(N-hydroxy-3-{[5-(N-hydroxyacetamido)pentyl]carbamoyl}propanamido)pentyl]butanediamide C25H48N6O8 560.353364
LMFA08020170 desferrioxamine D1 N-[5-(acetylamino)pentyl]-N'-(5-{[4-({5-[acetyl(hydroxy)amino]pentyl}amino)-4-oxobutanoyl](hydroxy)amino}pentyl)-N-hydroxybutanediamide C27H50N6O9 602.363929
LMFA08020171 desferrioxamine G 32-amino-5,16,27-trihydroxy-4,12,15,23,26-pentaoxo-5,11,16,22,27-pentaazadotriacontan-1-oic acid C27H50N6O10 618.358844
LMFA08020172 EI-1511-3 (2E,4E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-7-methylocta-2,4-dienamide C27H30N2O7 494.205303
LMFA08020173 EI-1511-5 (2E,4E,6E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-8-methyldeca-2,4,6-trienamide C29H32N2O7 520.220953
LMFA08020174 EI-1625-2 (2E)-N-[(1S,5R,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-4-methyloct-2-enamide C27H32N2O7 496.220953
LMFA08020175 Ferroxamine N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxo-butanoyl]-hydroxy-amino]pentyl]-N'-(5-aminopentyl)-N'-hydroxy-butanediamide;iron C25H48FeN6O8 616.288303